Reference : Controlled Comparison of Nefazodone and Amitriptyline in Major Depressive Inpatients
Scientific journals : Article
Human health sciences : Pharmacy, pharmacology & toxicology
http://hdl.handle.net/2268/249066
Controlled Comparison of Nefazodone and Amitriptyline in Major Depressive Inpatients
English
Ansseau, Marc mailto [Université de Liège - ULiège > Département des sciences cliniques > Psychiatrie et psychologie médicale]
Orban, Pierre [Université de Liège - ULiège > > Centre de recherches du cyclotron >]
Lecoq, Arlette [Université de Liège - ULiège > Département de personne et société > Département de personne et société >]
De Nayer, André Roch [Clinique Sainte-Thèrèse, Montignies-sur-Sambre > > > > > >]
Evrard, Jean-Luc [Clinique Sainte-Thèrèse, Montignies-sur-Sambre > > > > > >]
Kremer, Pierre [Clinique Sainte-Thèrèse, Montignies-sur-Sambre > > > > > >]
Devoitille, Jean-Michel [Hôpital du Petit Bourgogne, Liège > > > >]
Dierick, Michel [Sint-Camillus Hospital, Sint-Denijs-Westrem > > > > > >]
Mertens, Claudine [Psychiatrische Centra Sleidinge, Evergem-Sleidinge > > > > > >]
Mesotten, Frans [Kliniek van de Alexian Broeders, Munsterbilzen > > > > > >]
Mirel, Jean [Centre Hospitalier Vésale, Montigny-le-Tilleul > > > >]
Troisfontaines, Benoît [Clinique Saint Vincent, Rocourt > > > >]
van Moffaert, Myriam [Universitair Ziekenhuis Gent - UZ > > > >]
Vanbrabant, Emilie [Université de Liège - ULiège > > > >]
Jun-1994
Psychopharmacology
Springer
115
1-2
254-60
Yes (verified by ORBi)
International
0033-3158
1432-2072
Germany
[en] Amitriptyline ; Antidepressant ; Major depression ; Nefazodone
[en] Nefazodone, a phenylpiperazine antidepressant, exhibits novel dual activity on serotonin (5-HT) neurons; it binds to 5-HT2 receptors and inhibits 5-HT reuptake. Flexible doses of nefazodone (100-400 mg/day) and amitriptyline (50-200 mg/day) were compared in 106 major depressive inpatients in a 6-week double-blind study. Results showed significant superiority of amitriptyline over nefazodone on all rating instruments: Montgomery and Asberg depression rating scale (P < 0.0001), Hamilton depression scale (P < 0.0006), Clinical Global Impressions (P < 0.0001) and Patient Global Assessment (P < 0.01). A total of 65% of patients under amitriptyline and 56% of patients under nefazodone reported adverse events during the study, with significantly more dry mouth in the amitriptyline group (39% versus 11%, P = 0.001). Modal daily doses within the last treatment week reached 242 mg with nefazodone and 124 mg with amitriptyline. The lower efficacy of nefazodone, which contradicts comparative trials with imipramine in US patients, is discussed with regard to the dose of nefazodone, probably below the optimal therapeutic range for melancholic patients, and to the clinical differences between the patient samples.
Researchers ; Professionals ; Students
http://hdl.handle.net/2268/249066
10.1007/BF02244780

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
Controlled Comparison of Nefazodone and Amitriptyline in Major Depressive Inpatients.pdfPublisher postprint920.88 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.